Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk –a randomized controlled single-blind multicenter trial (DEBUT)

Presentation EuroPCR 2018

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk (DEBUT trial)

Presenter: Tuomas Rissanen

May 26, 2018

Presentation EuroPCR 2018

TARGET AC A prospective multicenter randomized post-market trial evaluating a novel Cobalt Chrome Rapamycin Drug Eluting Stent

Presenter: Andreas Baumbach

May 25, 2018

Presentation EuroPCR 2018

Real World Outcomes of TAVR with the SAPIEN-3 Valve in Intermediate Risk Patients: Comparison of Data from the TVT Registry with PARTNER S3 Studies

Presenter: E. Murat Tuzcu

May 25, 2018

Presentation EuroPCR 2018

Longevity of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients with Severe Aortic Stenosis and Lower Surgical Risk

Presenter: Lars Sondergaard

May 25, 2018

Presentation EuroPCR 2018

TIDES-ACS-Trial

Presenter: Pasi P. Karjalainen

May 25, 2018

Presentation EuroPCR 2018

Safety and performance of the resorbable magnesium scaffold, Magmaris in a real world setting - First 200 subjects at 12-month follow-up of the BIOSOLVE-IV registry

Presenter: Stefan Verheye

May 25, 2018

Presentation EuroPCR 2018

CE Mark Study of Transcatheter Mitral Valve Replacement for Severe Mitral Regurgitation: 30 day outcomes of the first 100 patients

Presenter: David Muller

May 25, 2018

Presentation EuroPCR 2018

30-day Outcomes of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification in the United States: Data from the STS/ACC/TVT Registry

Presenter: Mayra Guerrero

May 24, 2018

Presentation EuroPCR 2018

The MitrAl ValvE RepaIr Clinical (MAVERIC) EU/AU trial

Presenter: Simon Redwood

May 24, 2018

Presentation EuroPCR 2018

GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation (GIOTTO): Epidemiology and Acute Results

Presenter: Francesco Bedogni

May 23, 2018

Presentation EuroPCR 2018

Five-year Outcomes with PCI Guided by Fractional Flow Reserve in Patients with Stable Coronary Artery Disease (FAME 2)

Presenter: Panagiotis Xaplanteris

May 23, 2018

Presentation EuroPCR 2018

Anatomical Predictors of Stroke Prevention During Transcatheter Aortic Valve Implantation: The SENTINEL Trial

Presenter: Hasan Jilaihawi

May 23, 2018

Presentation EuroPCR 2018

Renal Denervation in the Presence of Antihypertensive Medications: Six-month Results from the Randomized, Blinded, Sham-controlled SPYRAL HTN-ON MED Trial

Presenter: David E. Kandzari

May 23, 2018

Presentation EuroPCR 2018

FFR-guided PCI versus Medical Therapy to Reduce Cardiac Death or Myocardial Infarction

Presenter: Frederik M. Zimmermann

May 23, 2018

Presentation EuroPCR 2018

PCI Statement on PCI Treatment for Chronic Coronary Syndrome

Presenter: Michael Haude

May 22, 2018

Presentation EuroPCR 2018

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

Presenter: Rasha Al-Lamee

May 22, 2018

Advertisement

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk (DEBUT trial)

TARGET AC A prospective multicenter randomized post-market trial evaluating a novel Cobalt Chrome Rapamycin Drug Eluting Stent

Real World Outcomes of TAVR with the SAPIEN-3 Valve in Intermediate Risk Patients: Comparison of Data from the TVT Registry with PARTNER S3 Studies

Longevity of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients with Severe Aortic Stenosis and Lower Surgical Risk

TIDES-ACS-Trial

Safety and performance of the resorbable magnesium scaffold, Magmaris in a real world setting - First 200 subjects at 12-month follow-up of the BIOSOLVE-IV registry

CE Mark Study of Transcatheter Mitral Valve Replacement for Severe Mitral Regurgitation: 30 day outcomes of the first 100 patients

30-day Outcomes of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification in the United States: Data from the STS/ACC/TVT Registry

The MitrAl ValvE RepaIr Clinical (MAVERIC) EU/AU trial

GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation (GIOTTO): Epidemiology and Acute Results

Five-year Outcomes with PCI Guided by Fractional Flow Reserve in Patients with Stable Coronary Artery Disease (FAME 2)

Anatomical Predictors of Stroke Prevention During Transcatheter Aortic Valve Implantation: The SENTINEL Trial

Renal Denervation in the Presence of Antihypertensive Medications: Six-month Results from the Randomized, Blinded, Sham-controlled SPYRAL HTN-ON MED Trial

FFR-guided PCI versus Medical Therapy to Reduce Cardiac Death or Myocardial Infarction

PCI Statement on PCI Treatment for Chronic Coronary Syndrome

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content